Funding
Funding not disclosed
Founders
Product
Problem
Many pediatric medications are not formulated specifically for children, leading to challenges in accurate dosing, palatability issues, and potential safety concerns. This can result in medication errors, reduced adherence, and suboptimal therapeutic outcomes for young patients.
Solution
PediaNano utilizes nanotechnology to develop enhanced drug formulations tailored for pediatric use. Their platform aims to improve dosing accuracy by creating precise, unit-dose medications. They also focus on enhancing palatability to increase acceptance and adherence among children. By reformulating existing drugs and developing new nano-enabled therapies, PediaNano seeks to improve the safety, efficacy, and overall experience of pediatric medication.
Target Audience
The primary target audience includes pharmaceutical companies seeking to expand their pediatric product lines, as well as pediatricians and parents looking for safer, more effective medication options for children.
Features
- Nanoparticle drug encapsulation for controlled release and improved bioavailability
- Taste-masking technologies to enhance palatability and reduce aversion
- Precise, unit-dose formulations to minimize dosing errors
- Development of age-appropriate dosage forms, such as liquid suspensions and chewable tablets
- Enhanced drug stability and shelf-life through nano-formulation